Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Transdermal Patch for Pain Relief Market Growth 2022-2028

  • LP 4886074
  • 117 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Transdermal Patch for Pain Relief will have significant change from previous year. According to our (LP Information) latest study, the global Transdermal Patch for Pain Relief market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Transdermal Patch for Pain Relief market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Transdermal Patch for Pain Relief market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Transdermal Patch for Pain Relief market, reaching US$ million by the year 2028. As for the Europe Transdermal Patch for Pain Relief landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Transdermal Patch for Pain Relief players cover Hisamitsu, Mylan, Johnson & Johnson, and Teva, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Patch for Pain Relief market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Lidocaine Patch

Diclofenac Patch

Indomethacin Patch

Fentanyl Patch

Peppermint Patch

Methyl Salicylate Patch

Capsaicin Patch

Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

OTC

Rx

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Hisamitsu

Mylan

Johnson & Johnson

Teva

Lingrui

Sanofi

Qizheng

Endo

Huarun 999

GSK

Haw Par

Nichiban

Laboratoires Genevrier

BLUE-EMU

IBSA Group

Pfizer

Performance Health

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Transdermal Patch for Pain Relief Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Transdermal Patch for Pain Relief by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Transdermal Patch for Pain Relief by Country/Region, 2017, 2022 & 2028

2.2 Transdermal Patch for Pain Relief Segment by Type

2.2.1 Lidocaine Patch

2.2.2 Diclofenac Patch

2.2.3 Indomethacin Patch

2.2.4 Fentanyl Patch

2.2.5 Peppermint Patch

2.2.6 Methyl Salicylate Patch

2.2.7 Capsaicin Patch

2.2.8 Other

2.3 Transdermal Patch for Pain Relief Sales by Type

2.3.1 Global Transdermal Patch for Pain Relief Sales Market Share by Type (2017-2022)

2.3.2 Global Transdermal Patch for Pain Relief Revenue and Market Share by Type (2017-2022)

2.3.3 Global Transdermal Patch for Pain Relief Sale Price by Type (2017-2022)

2.4 Transdermal Patch for Pain Relief Segment by Application

2.4.1 OTC

2.4.2 Rx

2.5 Transdermal Patch for Pain Relief Sales by Application

2.5.1 Global Transdermal Patch for Pain Relief Sale Market Share by Application (2017-2022)

2.5.2 Global Transdermal Patch for Pain Relief Revenue and Market Share by Application (2017-2022)

2.5.3 Global Transdermal Patch for Pain Relief Sale Price by Application (2017-2022)

3 Global Transdermal Patch for Pain Relief by Company

3.1 Global Transdermal Patch for Pain Relief Breakdown Data by Company

3.1.1 Global Transdermal Patch for Pain Relief Annual Sales by Company (2020-2022)

3.1.2 Global Transdermal Patch for Pain Relief Sales Market Share by Company (2020-2022)

3.2 Global Transdermal Patch for Pain Relief Annual Revenue by Company (2020-2022)

3.2.1 Global Transdermal Patch for Pain Relief Revenue by Company (2020-2022)

3.2.2 Global Transdermal Patch for Pain Relief Revenue Market Share by Company (2020-2022)

3.3 Global Transdermal Patch for Pain Relief Sale Price by Company

3.4 Key Manufacturers Transdermal Patch for Pain Relief Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Transdermal Patch for Pain Relief Product Location Distribution

3.4.2 Players Transdermal Patch for Pain Relief Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Transdermal Patch for Pain Relief by Geographic Region

4.1 World Historic Transdermal Patch for Pain Relief Market Size by Geographic Region (2017-2022)

4.1.1 Global Transdermal Patch for Pain Relief Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Transdermal Patch for Pain Relief Annual Revenue by Geographic Region

4.2 World Historic Transdermal Patch for Pain Relief Market Size by Country/Region (2017-2022)

4.2.1 Global Transdermal Patch for Pain Relief Annual Sales by Country/Region (2017-2022)

4.2.2 Global Transdermal Patch for Pain Relief Annual Revenue by Country/Region

4.3 Americas Transdermal Patch for Pain Relief Sales Growth

4.4 APAC Transdermal Patch for Pain Relief Sales Growth

4.5 Europe Transdermal Patch for Pain Relief Sales Growth

4.6 Middle East & Africa Transdermal Patch for Pain Relief Sales Growth

5 Americas

5.1 Americas Transdermal Patch for Pain Relief Sales by Country

5.1.1 Americas Transdermal Patch for Pain Relief Sales by Country (2017-2022)

5.1.2 Americas Transdermal Patch for Pain Relief Revenue by Country (2017-2022)

5.2 Americas Transdermal Patch for Pain Relief Sales by Type

5.3 Americas Transdermal Patch for Pain Relief Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Transdermal Patch for Pain Relief Sales by Region

6.1.1 APAC Transdermal Patch for Pain Relief Sales by Region (2017-2022)

6.1.2 APAC Transdermal Patch for Pain Relief Revenue by Region (2017-2022)

6.2 APAC Transdermal Patch for Pain Relief Sales by Type

6.3 APAC Transdermal Patch for Pain Relief Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Transdermal Patch for Pain Relief by Country

7.1.1 Europe Transdermal Patch for Pain Relief Sales by Country (2017-2022)

7.1.2 Europe Transdermal Patch for Pain Relief Revenue by Country (2017-2022)

7.2 Europe Transdermal Patch for Pain Relief Sales by Type

7.3 Europe Transdermal Patch for Pain Relief Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Transdermal Patch for Pain Relief by Country

8.1.1 Middle East & Africa Transdermal Patch for Pain Relief Sales by Country (2017-2022)

8.1.2 Middle East & Africa Transdermal Patch for Pain Relief Revenue by Country (2017-2022)

8.2 Middle East & Africa Transdermal Patch for Pain Relief Sales by Type

8.3 Middle East & Africa Transdermal Patch for Pain Relief Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Transdermal Patch for Pain Relief

10.3 Manufacturing Process Analysis of Transdermal Patch for Pain Relief

10.4 Industry Chain Structure of Transdermal Patch for Pain Relief

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Transdermal Patch for Pain Relief Distributors

11.3 Transdermal Patch for Pain Relief Customer

12 World Forecast Review for Transdermal Patch for Pain Relief by Geographic Region

12.1 Global Transdermal Patch for Pain Relief Market Size Forecast by Region

12.1.1 Global Transdermal Patch for Pain Relief Forecast by Region (2023-2028)

12.1.2 Global Transdermal Patch for Pain Relief Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Transdermal Patch for Pain Relief Forecast by Type

12.7 Global Transdermal Patch for Pain Relief Forecast by Application

13 Key Players Analysis

13.1 Hisamitsu

13.1.1 Hisamitsu Company Information

13.1.2 Hisamitsu Transdermal Patch for Pain Relief Product Offered

13.1.3 Hisamitsu Transdermal Patch for Pain Relief Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Hisamitsu Main Business Overview

13.1.5 Hisamitsu Latest Developments

13.2 Mylan

13.2.1 Mylan Company Information

13.2.2 Mylan Transdermal Patch for Pain Relief Product Offered

13.2.3 Mylan Transdermal Patch for Pain Relief Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Mylan Main Business Overview

13.2.5 Mylan Latest Developments

13.3 Johnson & Johnson

13.3.1 Johnson & Johnson Company Information

13.3.2 Johnson & Johnson Transdermal Patch for Pain Relief Product Offered

13.3.3 Johnson & Johnson Transdermal Patch for Pain Relief Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Johnson & Johnson Main Business Overview

13.3.5 Johnson & Johnson Latest Developments

13.4 Teva

13.4.1 Teva Company Information

13.4.2 Teva Transdermal Patch for Pain Relief Product Offered

13.4.3 Teva Transdermal Patch for Pain Relief Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Teva Main Business Overview

13.4.5 Teva Latest Developments

13.5 Lingrui

13.5.1 Lingrui Company Information

13.5.2 Lingrui Transdermal Patch for Pain Relief Product Offered

13.5.3 Lingrui Transdermal Patch for Pain Relief Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Lingrui Main Business Overview

13.5.5 Lingrui Latest Developments

13.6 Sanofi

13.6.1 Sanofi Company Information

13.6.2 Sanofi Transdermal Patch for Pain Relief Product Offered

13.6.3 Sanofi Transdermal Patch for Pain Relief Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Sanofi Main Business Overview

13.6.5 Sanofi Latest Developments

13.7 Qizheng

13.7.1 Qizheng Company Information

13.7.2 Qizheng Transdermal Patch for Pain Relief Product Offered

13.7.3 Qizheng Transdermal Patch for Pain Relief Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Qizheng Main Business Overview

13.7.5 Qizheng Latest Developments

13.8 Endo

13.8.1 Endo Company Information

13.8.2 Endo Transdermal Patch for Pain Relief Product Offered

13.8.3 Endo Transdermal Patch for Pain Relief Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Endo Main Business Overview

13.8.5 Endo Latest Developments

13.9 Huarun 999

13.9.1 Huarun 999 Company Information

13.9.2 Huarun 999 Transdermal Patch for Pain Relief Product Offered

13.9.3 Huarun 999 Transdermal Patch for Pain Relief Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Huarun 999 Main Business Overview

13.9.5 Huarun 999 Latest Developments

13.10 GSK

13.10.1 GSK Company Information

13.10.2 GSK Transdermal Patch for Pain Relief Product Offered

13.10.3 GSK Transdermal Patch for Pain Relief Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 GSK Main Business Overview

13.10.5 GSK Latest Developments

13.11 Haw Par

13.11.1 Haw Par Company Information

13.11.2 Haw Par Transdermal Patch for Pain Relief Product Offered

13.11.3 Haw Par Transdermal Patch for Pain Relief Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Haw Par Main Business Overview

13.11.5 Haw Par Latest Developments

13.12 Nichiban

13.12.1 Nichiban Company Information

13.12.2 Nichiban Transdermal Patch for Pain Relief Product Offered

13.12.3 Nichiban Transdermal Patch for Pain Relief Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Nichiban Main Business Overview

13.12.5 Nichiban Latest Developments

13.13 Laboratoires Genevrier

13.13.1 Laboratoires Genevrier Company Information

13.13.2 Laboratoires Genevrier Transdermal Patch for Pain Relief Product Offered

13.13.3 Laboratoires Genevrier Transdermal Patch for Pain Relief Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Laboratoires Genevrier Main Business Overview

13.13.5 Laboratoires Genevrier Latest Developments

13.14 BLUE-EMU

13.14.1 BLUE-EMU Company Information

13.14.2 BLUE-EMU Transdermal Patch for Pain Relief Product Offered

13.14.3 BLUE-EMU Transdermal Patch for Pain Relief Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 BLUE-EMU Main Business Overview

13.14.5 BLUE-EMU Latest Developments

13.15 IBSA Group

13.15.1 IBSA Group Company Information

13.15.2 IBSA Group Transdermal Patch for Pain Relief Product Offered

13.15.3 IBSA Group Transdermal Patch for Pain Relief Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 IBSA Group Main Business Overview

13.15.5 IBSA Group Latest Developments

13.16 Pfizer

13.16.1 Pfizer Company Information

13.16.2 Pfizer Transdermal Patch for Pain Relief Product Offered

13.16.3 Pfizer Transdermal Patch for Pain Relief Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Pfizer Main Business Overview

13.16.5 Pfizer Latest Developments

13.17 Performance Health

13.17.1 Performance Health Company Information

13.17.2 Performance Health Transdermal Patch for Pain Relief Product Offered

13.17.3 Performance Health Transdermal Patch for Pain Relief Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Performance Health Main Business Overview

13.17.5 Performance Health Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Transdermal Patch for Pain Relief Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Transdermal Patch for Pain Relief Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Lidocaine Patch

Table 4. Major Players of Diclofenac Patch

Table 5. Major Players of Indomethacin Patch

Table 6. Major Players of Fentanyl Patch

Table 7. Major Players of Peppermint Patch

Table 8. Major Players of Methyl Salicylate Patch

Table 9. Major Players of Capsaicin Patch

Table 10. Major Players of Other

Table 11. Global Transdermal Patch for Pain Relief Sales by Type (2017-2022) & (K Units)

Table 12. Global Transdermal Patch for Pain Relief Sales Market Share by Type (2017-2022)

Table 13. Global Transdermal Patch for Pain Relief Revenue by Type (2017-2022) & ($ million)

Table 14. Global Transdermal Patch for Pain Relief Revenue Market Share by Type (2017-2022)

Table 15. Global Transdermal Patch for Pain Relief Sale Price by Type (2017-2022) & (US$/Unit)

Table 16. Global Transdermal Patch for Pain Relief Sales by Application (2017-2022) & (K Units)

Table 17. Global Transdermal Patch for Pain Relief Sales Market Share by Application (2017-2022)

Table 18. Global Transdermal Patch for Pain Relief Revenue by Application (2017-2022)

Table 19. Global Transdermal Patch for Pain Relief Revenue Market Share by Application (2017-2022)

Table 20. Global Transdermal Patch for Pain Relief Sale Price by Application (2017-2022) & (US$/Unit)

Table 21. Global Transdermal Patch for Pain Relief Sales by Company (2020-2022) & (K Units)

Table 22. Global Transdermal Patch for Pain Relief Sales Market Share by Company (2020-2022)

Table 23. Global Transdermal Patch for Pain Relief Revenue by Company (2020-2022) ($ Millions)

Table 24. Global Transdermal Patch for Pain Relief Revenue Market Share by Company (2020-2022)

Table 25. Global Transdermal Patch for Pain Relief Sale Price by Company (2020-2022) & (US$/Unit)

Table 26. Key Manufacturers Transdermal Patch for Pain Relief Producing Area Distribution and Sales Area

Table 27. Players Transdermal Patch for Pain Relief Products Offered

Table 28. Transdermal Patch for Pain Relief Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 29. New Products and Potential Entrants

Table 30. Mergers & Acquisitions, Expansion

Table 31. Global Transdermal Patch for Pain Relief Sales by Geographic Region (2017-2022) & (K Units)

Table 32. Global Transdermal Patch for Pain Relief Sales Market Share Geographic Region (2017-2022)

Table 33. Global Transdermal Patch for Pain Relief Revenue by Geographic Region (2017-2022) & ($ millions)

Table 34. Global Transdermal Patch for Pain Relief Revenue Market Share by Geographic Region (2017-2022)

Table 35. Global Transdermal Patch for Pain Relief Sales by Country/Region (2017-2022) & (K Units)

Table 36. Global Transdermal Patch for Pain Relief Sales Market Share by Country/Region (2017-2022)

Table 37. Global Transdermal Patch for Pain Relief Revenue by Country/Region (2017-2022) & ($ millions)

Table 38. Global Transdermal Patch for Pain Relief Revenue Market Share by Country/Region (2017-2022)

Table 39. Americas Transdermal Patch for Pain Relief Sales by Country (2017-2022) & (K Units)

Table 40. Americas Transdermal Patch for Pain Relief Sales Market Share by Country (2017-2022)

Table 41. Americas Transdermal Patch for Pain Relief Revenue by Country (2017-2022) & ($ Millions)

Table 42. Americas Transdermal Patch for Pain Relief Revenue Market Share by Country (2017-2022)

Table 43. Americas Transdermal Patch for Pain Relief Sales by Type (2017-2022) & (K Units)

Table 44. Americas Transdermal Patch for Pain Relief Sales Market Share by Type (2017-2022)

Table 45. Americas Transdermal Patch for Pain Relief Sales by Application (2017-2022) & (K Units)

Table 46. Americas Transdermal Patch for Pain Relief Sales Market Share by Application (2017-2022)

Table 47. APAC Transdermal Patch for Pain Relief Sales by Region (2017-2022) & (K Units)

Table 48. APAC Transdermal Patch for Pain Relief Sales Market Share by Region (2017-2022)

Table 49. APAC Transdermal Patch for Pain Relief Revenue by Region (2017-2022) & ($ Millions)

Table 50. APAC Transdermal Patch for Pain Relief Revenue Market Share by Region (2017-2022)

Table 51. APAC Transdermal Patch for Pain Relief Sales by Type (2017-2022) & (K Units)

Table 52. APAC Transdermal Patch for Pain Relief Sales Market Share by Type (2017-2022)

Table 53. APAC Transdermal Patch for Pain Relief Sales by Application (2017-2022) & (K Units)

Table 54. APAC Transdermal Patch for Pain Relief Sales Market Share by Application (2017-2022)

Table 55. Europe Transdermal Patch for Pain Relief Sales by Country (2017-2022) & (K Units)

Table 56. Europe Transdermal Patch for Pain Relief Sales Market Share by Country (2017-2022)

Table 57. Europe Transdermal Patch for Pain Relief Revenue by Country (2017-2022) & ($ Millions)

Table 58. Europe Transdermal Patch for Pain Relief Revenue Market Share by Country (2017-2022)

Table 59. Europe Transdermal Patch for Pain Relief Sales by Type (2017-2022) & (K Units)

Table 60. Europe Transdermal Patch for Pain Relief Sales Market Share by Type (2017-2022)

Table 61. Europe Transdermal Patch for Pain Relief Sales by Application (2017-2022) & (K Units)

Table 62. Europe Transdermal Patch for Pain Relief Sales Market Share by Application (2017-2022)

Table 63. Middle East & Africa Transdermal Patch for Pain Relief Sales by Country (2017-2022) & (K Units)

Table 64. Middle East & Africa Transdermal Patch for Pain Relief Sales Market Share by Country (2017-2022)

Table 65. Middle East & Africa Transdermal Patch for Pain Relief Revenue by Country (2017-2022) & ($ Millions)

Table 66. Middle East & Africa Transdermal Patch for Pain Relief Revenue Market Share by Country (2017-2022)

Table 67. Middle East & Africa Transdermal Patch for Pain Relief Sales by Type (2017-2022) & (K Units)

Table 68. Middle East & Africa Transdermal Patch for Pain Relief Sales Market Share by Type (2017-2022)

Table 69. Middle East & Africa Transdermal Patch for Pain Relief Sales by Application (2017-2022) & (K Units)

Table 70. Middle East & Africa Transdermal Patch for Pain Relief Sales Market Share by Application (2017-2022)

Table 71. Key Market Drivers & Growth Opportunities of Transdermal Patch for Pain Relief

Table 72. Key Market Challenges & Risks of Transdermal Patch for Pain Relief

Table 73. Key Industry Trends of Transdermal Patch for Pain Relief

Table 74. Transdermal Patch for Pain Relief Raw Material

Table 75. Key Suppliers of Raw Materials

Table 76. Transdermal Patch for Pain Relief Distributors List

Table 77. Transdermal Patch for Pain Relief Customer List

Table 78. Global Transdermal Patch for Pain Relief Sales Forecast by Region (2023-2028) & (K Units)

Table 79. Global Transdermal Patch for Pain Relief Sales Market Forecast by Region

Table 80. Global Transdermal Patch for Pain Relief Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Global Transdermal Patch for Pain Relief Revenue Market Share Forecast by Region (2023-2028)

Table 82. Americas Transdermal Patch for Pain Relief Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Americas Transdermal Patch for Pain Relief Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. APAC Transdermal Patch for Pain Relief Sales Forecast by Region (2023-2028) & (K Units)

Table 85. APAC Transdermal Patch for Pain Relief Revenue Forecast by Region (2023-2028) & ($ millions)

Table 86. Europe Transdermal Patch for Pain Relief Sales Forecast by Country (2023-2028) & (K Units)

Table 87. Europe Transdermal Patch for Pain Relief Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Middle East & Africa Transdermal Patch for Pain Relief Sales Forecast by Country (2023-2028) & (K Units)

Table 89. Middle East & Africa Transdermal Patch for Pain Relief Revenue Forecast by Country (2023-2028) & ($ millions)

Table 90. Global Transdermal Patch for Pain Relief Sales Forecast by Type (2023-2028) & (K Units)

Table 91. Global Transdermal Patch for Pain Relief Sales Market Share Forecast by Type (2023-2028)

Table 92. Global Transdermal Patch for Pain Relief Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 93. Global Transdermal Patch for Pain Relief Revenue Market Share Forecast by Type (2023-2028)

Table 94. Global Transdermal Patch for Pain Relief Sales Forecast by Application (2023-2028) & (K Units)

Table 95. Global Transdermal Patch for Pain Relief Sales Market Share Forecast by Application (2023-2028)

Table 96. Global Transdermal Patch for Pain Relief Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 97. Global Transdermal Patch for Pain Relief Revenue Market Share Forecast by Application (2023-2028)

Table 98. Hisamitsu Basic Information, Transdermal Patch for Pain Relief Manufacturing Base, Sales Area and Its Competitors

Table 99. Hisamitsu Transdermal Patch for Pain Relief Product Offered

Table 100. Hisamitsu Transdermal Patch for Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Hisamitsu Main Business

Table 102. Hisamitsu Latest Developments

Table 103. Mylan Basic Information, Transdermal Patch for Pain Relief Manufacturing Base, Sales Area and Its Competitors

Table 104. Mylan Transdermal Patch for Pain Relief Product Offered

Table 105. Mylan Transdermal Patch for Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Mylan Main Business

Table 107. Mylan Latest Developments

Table 108. Johnson & Johnson Basic Information, Transdermal Patch for Pain Relief Manufacturing Base, Sales Area and Its Competitors

Table 109. Johnson & Johnson Transdermal Patch for Pain Relief Product Offered

Table 110. Johnson & Johnson Transdermal Patch for Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Johnson & Johnson Main Business

Table 112. Johnson & Johnson Latest Developments

Table 113. Teva Basic Information, Transdermal Patch for Pain Relief Manufacturing Base, Sales Area and Its Competitors

Table 114. Teva Transdermal Patch for Pain Relief Product Offered

Table 115. Teva Transdermal Patch for Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Teva Main Business

Table 117. Teva Latest Developments

Table 118. Lingrui Basic Information, Transdermal Patch for Pain Relief Manufacturing Base, Sales Area and Its Competitors

Table 119. Lingrui Transdermal Patch for Pain Relief Product Offered

Table 120. Lingrui Transdermal Patch for Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Lingrui Main Business

Table 122. Lingrui Latest Developments

Table 123. Sanofi Basic Information, Transdermal Patch for Pain Relief Manufacturing Base, Sales Area and Its Competitors

Table 124. Sanofi Transdermal Patch for Pain Relief Product Offered

Table 125. Sanofi Transdermal Patch for Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Sanofi Main Business

Table 127. Sanofi Latest Developments

Table 128. Qizheng Basic Information, Transdermal Patch for Pain Relief Manufacturing Base, Sales Area and Its Competitors

Table 129. Qizheng Transdermal Patch for Pain Relief Product Offered

Table 130. Qizheng Transdermal Patch for Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Qizheng Main Business

Table 132. Qizheng Latest Developments

Table 133. Endo Basic Information, Transdermal Patch for Pain Relief Manufacturing Base, Sales Area and Its Competitors

Table 134. Endo Transdermal Patch for Pain Relief Product Offered

Table 135. Endo Transdermal Patch for Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. Endo Main Business

Table 137. Endo Latest Developments

Table 138. Huarun 999 Basic Information, Transdermal Patch for Pain Relief Manufacturing Base, Sales Area and Its Competitors

Table 139. Huarun 999 Transdermal Patch for Pain Relief Product Offered

Table 140. Huarun 999 Transdermal Patch for Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Huarun 999 Main Business

Table 142. Huarun 999 Latest Developments

Table 143. GSK Basic Information, Transdermal Patch for Pain Relief Manufacturing Base, Sales Area and Its Competitors

Table 144. GSK Transdermal Patch for Pain Relief Product Offered

Table 145. GSK Transdermal Patch for Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. GSK Main Business

Table 147. GSK Latest Developments

Table 148. Haw Par Basic Information, Transdermal Patch for Pain Relief Manufacturing Base, Sales Area and Its Competitors

Table 149. Haw Par Transdermal Patch for Pain Relief Product Offered

Table 150. Haw Par Transdermal Patch for Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 151. Haw Par Main Business

Table 152. Haw Par Latest Developments

Table 153. Nichiban Basic Information, Transdermal Patch for Pain Relief Manufacturing Base, Sales Area and Its Competitors

Table 154. Nichiban Transdermal Patch for Pain Relief Product Offered

Table 155. Nichiban Transdermal Patch for Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 156. Nichiban Main Business

Table 157. Nichiban Latest Developments

Table 158. Laboratoires Genevrier Basic Information, Transdermal Patch for Pain Relief Manufacturing Base, Sales Area and Its Competitors

Table 159. Laboratoires Genevrier Transdermal Patch for Pain Relief Product Offered

Table 160. Laboratoires Genevrier Transdermal Patch for Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 161. Laboratoires Genevrier Main Business

Table 162. Laboratoires Genevrier Latest Developments

Table 163. BLUE-EMU Basic Information, Transdermal Patch for Pain Relief Manufacturing Base, Sales Area and Its Competitors

Table 164. BLUE-EMU Transdermal Patch for Pain Relief Product Offered

Table 165. BLUE-EMU Transdermal Patch for Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 166. BLUE-EMU Main Business

Table 167. BLUE-EMU Latest Developments

Table 168. IBSA Group Basic Information, Transdermal Patch for Pain Relief Manufacturing Base, Sales Area and Its Competitors

Table 169. IBSA Group Transdermal Patch for Pain Relief Product Offered

Table 170. IBSA Group Transdermal Patch for Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 171. IBSA Group Main Business

Table 172. IBSA Group Latest Developments

Table 173. Pfizer Basic Information, Transdermal Patch for Pain Relief Manufacturing Base, Sales Area and Its Competitors

Table 174. Pfizer Transdermal Patch for Pain Relief Product Offered

Table 175. Pfizer Transdermal Patch for Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 176. Pfizer Main Business

Table 177. Pfizer Latest Developments

Table 178. Performance Health Basic Information, Transdermal Patch for Pain Relief Manufacturing Base, Sales Area and Its Competitors

Table 179. Performance Health Transdermal Patch for Pain Relief Product Offered

Table 180. Performance Health Transdermal Patch for Pain Relief Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 181. Performance Health Main Business

Table 182. Performance Health Latest Developments

List of Figures

Figure 1. Picture of Transdermal Patch for Pain Relief

Figure 2. Transdermal Patch for Pain Relief Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Transdermal Patch for Pain Relief Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Transdermal Patch for Pain Relief Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Transdermal Patch for Pain Relief Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Lidocaine Patch

Figure 10. Product Picture of Diclofenac Patch

Figure 11. Product Picture of Indomethacin Patch

Figure 12. Product Picture of Fentanyl Patch

Figure 13. Product Picture of Peppermint Patch

Figure 14. Product Picture of Methyl Salicylate Patch

Figure 15. Product Picture of Capsaicin Patch

Figure 16. Product Picture of Other

Figure 17. Global Transdermal Patch for Pain Relief Sales Market Share by Type in 2021

Figure 18. Global Transdermal Patch for Pain Relief Revenue Market Share by Type (2017-2022)

Figure 19. Transdermal Patch for Pain Relief Consumed in OTC

Figure 20. Global Transdermal Patch for Pain Relief Market: OTC (2017-2022) & (K Units)

Figure 21. Transdermal Patch for Pain Relief Consumed in Rx

Figure 22. Global Transdermal Patch for Pain Relief Market: Rx (2017-2022) & (K Units)

Figure 23. Global Transdermal Patch for Pain Relief Sales Market Share by Application (2017-2022)

Figure 24. Global Transdermal Patch for Pain Relief Revenue Market Share by Application in 2021

Figure 25. Transdermal Patch for Pain Relief Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Transdermal Patch for Pain Relief Revenue Market Share by Company in 2021

Figure 27. Global Transdermal Patch for Pain Relief Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Transdermal Patch for Pain Relief Revenue Market Share by Geographic Region in 2021

Figure 29. Global Transdermal Patch for Pain Relief Sales Market Share by Region (2017-2022)

Figure 30. Global Transdermal Patch for Pain Relief Revenue Market Share by Country/Region in 2021

Figure 31. Americas Transdermal Patch for Pain Relief Sales 2017-2022 (K Units)

Figure 32. Americas Transdermal Patch for Pain Relief Revenue 2017-2022 ($ Millions)

Figure 33. APAC Transdermal Patch for Pain Relief Sales 2017-2022 (K Units)

Figure 34. APAC Transdermal Patch for Pain Relief Revenue 2017-2022 ($ Millions)

Figure 35. Europe Transdermal Patch for Pain Relief Sales 2017-2022 (K Units)

Figure 36. Europe Transdermal Patch for Pain Relief Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Transdermal Patch for Pain Relief Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa Transdermal Patch for Pain Relief Revenue 2017-2022 ($ Millions)

Figure 39. Americas Transdermal Patch for Pain Relief Sales Market Share by Country in 2021

Figure 40. Americas Transdermal Patch for Pain Relief Revenue Market Share by Country in 2021

Figure 41. United States Transdermal Patch for Pain Relief Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Transdermal Patch for Pain Relief Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Transdermal Patch for Pain Relief Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Transdermal Patch for Pain Relief Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Transdermal Patch for Pain Relief Sales Market Share by Region in 2021

Figure 46. APAC Transdermal Patch for Pain Relief Revenue Market Share by Regions in 2021

Figure 47. China Transdermal Patch for Pain Relief Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Transdermal Patch for Pain Relief Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Transdermal Patch for Pain Relief Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Transdermal Patch for Pain Relief Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Transdermal Patch for Pain Relief Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Transdermal Patch for Pain Relief Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Transdermal Patch for Pain Relief Sales Market Share by Country in 2021

Figure 54. Europe Transdermal Patch for Pain Relief Revenue Market Share by Country in 2021

Figure 55. Germany Transdermal Patch for Pain Relief Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Transdermal Patch for Pain Relief Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Transdermal Patch for Pain Relief Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Transdermal Patch for Pain Relief Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Transdermal Patch for Pain Relief Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Transdermal Patch for Pain Relief Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Transdermal Patch for Pain Relief Revenue Market Share by Country in 2021

Figure 62. Egypt Transdermal Patch for Pain Relief Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Transdermal Patch for Pain Relief Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Transdermal Patch for Pain Relief Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Transdermal Patch for Pain Relief Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Transdermal Patch for Pain Relief Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Transdermal Patch for Pain Relief in 2021

Figure 68. Manufacturing Process Analysis of Transdermal Patch for Pain Relief

Figure 69. Industry Chain Structure of Transdermal Patch for Pain Relief

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390